[ad_1]
A new study demonstrated how a blood test can help identify people who may develop cancer since ] lung caused by its exposure at tobacco .
According to researchers at the International Agency for Research on Cancer (IARC) "using information from four biomarkers of blood proteins as well as information on tobacco, we were able to identify 63% future patients with lung cancer among active smokers and ex-smokers . "
According to medical specialist Mattias Johansson, one of the leading Study researchers have shown that biomarkers have the potential to dramatically improve the identification of those who are most likely to benefit from screening.
"Early detection plays a key role in reducing deaths from this disease." "These promising results from laboratory biomarkers offer new opportunities to improve patient survival with lung cancer," said IARC Director Christopher Salvaje.
>> Dolly opens the door to cloning 22 years ago: Other cases
For its part, the head of the IARC Genetics Section and one of the leading researchers in the study Paul Brennan added that this study is the first to show that a panel of protein markers can improve the identification of future cases of lung cancer.
Brennan added that this test could be used to improve current eligibility criteria for screening and increase the benefits of disease detection.
>> Remains of the largest carnivorous dinosaur in Europe
[ad_2]
Source link
